News
Sterile fecal filtrate effectively treated recurrent CDI
Sterile fecal filtrate transplantation (FFT) effectively treated five cases of symptomatic chronic-relapsing Clostridium difficile infection,...
News
Endoscopic resection alone sufficed in many T1 colorectal cancers
Patients with T1 colorectal cancer might not benefit from additional surgery after endoscopic resection unless they have positive or indeterminate...
Article
Rituximab after ASCT boosted survival in mantle cell lymphoma
SAN DIEGO – Maintenance therapy every other month with rituximab significantly prolonged event-free and overall survival after autologous stem...
Article
Ultrashort course antibiotics may be enough in stable VAP
Ultrashort antibiotic courses yielded outcomes that were similar to those with longer courses in patients with suspected ventilator-associated...
Video
VIDEO: Despite toxicities, ibrutinib is beneficial for treatment-resistant graft-vs.-host disease
SAN DIEGO – An oral regimen of 420 mg ibrutinib achieved complete response in one-third of allogeneic stem cell recipients with chronic graft-vs.-...
News
Bortezomib bolsters hematologic response in AL amyloidosis
SAN DIEGO – Adding bortezomib (B) to melphalan and dexamethasone (MDex) bolstered hematologic response in immunoglobulin light-chain (AL)...
Article
FDG-PET/CT at maintenance predicts myeloma survival
SAN DIEGO – FDG-PET/CT helped predict survival in newly diagnosed multiple myeloma, regardless of induction regimen.
Article
Chemo-free induction regimen shines in MCL
SAN DIEGO – A chemotherapy-free induction regimen of ibrutinib and rituximab was well tolerated and achieved an overall response rate of 100%...
Article
International survey uncovered gaps in sun-protective behaviors
In a global survey, 88% of respondents knew that unprotected sun exposure leads to skin cancer, but less than 60% “always” or “often” applied...
Article
Lenalidomide maintenance extended progression-free survival in high-risk CLL
SAN DIEGO - Lenalidomide maintenance may be an option for patients with chronic lymphocytic leukemia at risk of early progression.
Article
Rituximab vanquished MRD in mantle cell lymphoma
SAN DIEGO – Rituximab can at least temporarily vanquish minimal residual disease in mantle cell lymphoma patients who relapse after induction...
Article
Adjuvant chemo prolonged survival after radical nephroureterectomy
Adjuvant chemotherapy prolonged survival after radical nephroureterectomy by nearly a year, compared with observation alone, among patients with...
Article
PERSIST-2 might allay some concerns about pacritinib in myelofibrosis
SAN DIEGO – Late-breaking results from the phase III PERSIST-2 trial may ease at least some safety concerns surrounding the use of pacritinib in...
Article
Adding epoetin alfa to lenalidomide boosted myelodysplastic syndrome responses
SAN DIEGO – Dual therapy with lenalidomide and epoetin alfa was safe and led to freedom from transfusion significantly more often than...
Article
Daratumumab combo holds up across POLLUX myeloma subgroups
SAN DIEGO – Adding daratumumab (D) to lenalidomide and dexamethasone (Rd) significantly improved outcomes in patients with relapsed and refractory...